Introduction
Osteoarthritis (OA) of the carpo-metacarpal joint of the thumb is a common condition, affecting at least 30% of women over the age of 65 (1) . The life impact and disability associated to hand OA are significant. Hand disability is frequent in patients suffering from thumb OA, with a reduction of grip strength and difficulty writing or fingering small objects (2, 3) . Few treatments have been assessed in thumb OA. According to the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) recommendations, the optimal management of thumb OA requires a combination of non-pharmacological measures such as local application of heat or splints, and pharmacological treatment modalities (4, 5) . Local treatments are preferred to systemic treatments. For intra-articular injections, experts' opinion differs in thumb OA (4, 5) . Evidence of efficacy of intra-articular hyaluronic acid or corticosteroid injections in thumb OA is scarce, while largely investigated in hip and knee (6 -10) . For example in knee OA, intra-articular corticosteroids are reported to decrease pain (10) whereas hyaluronic acid injection seems to relieve pain and to improve functional capacity (7) (8) (9) . Both of these modalities are recommended by international associations for the treatment of lower-limb OA (4, 11, 12) . In thumb OA, corticosteroid injections are recommended, and hyaluronic acid injections may be useful, according to the EULAR experts (5) . However both of these injection modalities are not recommended by the ACR experts (4) . The objective of the present study was to assess short-term and medium-term efficacy on pain, functional capacity and pulp pinch force of intra-articular injections of corticosteroids or hyaluronic acid in patients with thumb OA in controlled trials, by performing a meta-analysis of published articles. . The limits were English, French, German or Spanish language and controlled trials. In addition, the Cochrane database, reference lists of the papers initially detected to identify additional relevant reports were manually searched, as were EULAR, OARSI and ACR abstracts of the last 5 years. Studies were initially selected on their title and abstract by one author (ST), then on their full text. All controlled trials reporting the efficacy on pain and/or functional capacity and/or pulp pinch force of intra-articular injections of corticosteroids and/or hyaluronic acid in thumb OA, were selected. For studies with incomplete data, the corresponding authors were contacted by email.
Methods

Data collection:
Using a predetermined form, the following features were collected: blinding, intention-to-treat analysis and number of participants who completed the follow-up. The Jadad scale (13) was applied to assess the methodological quality: 5 points can be awarded, with higher scores indicating higher quality. The Cochrane risk of bias tools was also applied. For each trial, demographic characteristics (sex, mean age), thumb OA features, type of corticosteroids and/or hyaluronic acid (with doses and number of injections), type of placebo if needed and duration of follow-up were collected. Pain was extracted from the studies by a 100mm visual analogue scale; functional capacity was extracted as available by the following scores: Disabilities of the Arm, Shoulder and Hand (14) , the Dreiser functional index (15) , the Purdue Pegboard Test (16) and/or the Duruöz Hand Index (17); because functional capacity was assessed by different scores, each score was transformed linearly to fit the range 0-100, in which 0 was the best situation and 100 the worst. Pulp pinch force was extracted by pulp to pulp pinch force in pounds (18) .
Studies were classified according to the injection type (hyaluronic acid versus placebo, corticosteroids versus placebo and hyaluronic acid versus corticosteroids). Efficacy was assessed by the change in pain and/or functional capacity and/or pulp pinch force status between baseline and week 4, week 12 and week 24 to 26 (as available according to the studies, called week 24 in the text) in corticosteroids, hyaluronic acid and placebo groups.
Statistical analysis
In each study, the standardized response mean (SRM) was determined to assess the magnitude of treatment effect. The SRM is calculated as the mean change divided by the standard deviation of the change. Improvement was considered as a positive change. Pooled SRMs were calculated by meta-analysis, using the Mantel-Haenszel method with RevMan version 5.2 statistical software (Review Manager, Copenhagen, Denmark). Statistical heterogeneity was measured by I². All meta-analyses were carried out with use of random effects model in case of significant heterogeneity.
Results
Literature search results and trial characteristics Initially, 84 potentially relevant articles were screened; 76 were excluded ( Figure 1 ). For 3 studies, the results described in the articles did not allow meta-analysis, but the studies are reported descriptively here ( Table 1) . The methodological quality was moderate: the mean Jadad score was 2.2 (SD 2.8) (range 1-5); 4 (67%) trials performed intention-to-treat analyses. Of the 6 trials, 3 described precisely the patient selection or outcome, 2 used a concealed random allocation, 5 presented difference in changes with standard error of the mean and 1 with interquartile range. The Cochrane risk of bias tool also indicated moderate quality (online figure S2) . The injection was guided by X-ray in 2 studies, by ultrasound in 1 study and not guided in 3 studies. The number of injections varied across studies and sometimes across study groups (Table 1) . Heterogeneity was substantial, varying between 0 and 97 for I 2 across the analyses.
Efficacy of corticosteroids injections versus placebo
Mandl's study (23) indicated no difference on pain at week 24 between two groups of 62 patients with 2 injections (Table 2 ). Meenagh's study (24) compared 2 groups of 20 patients with one injection, and showed efficacy for corticosteroids on pain at week 24 with a large effect size (Table  2 ). Heyworth's study (21) indicated no difference on pain at week 24 after 2 injections between corticosteroids (22 patients) and placebo (18 patients), but the data could not be included in the meta-analysis (Table 3 ). The pooled analysis (82 patients in each arm) showed no difference between the two treatments for pain (SRM = -1.20 [-3.69; 1.29]) (online figure S1 and Table 3 ).
Efficacy of hyaluronic acid injections versus placebo
Roux's study (26) compared one versus three injection of hyaluronic acid with 14 patients in each group at week 12. Patients who received one injection of hyaluronic acid were considered as placebo (Table 1) . It showed efficacy on pain and functional capacity at week 12 for 3 injections with a large effect size (Table 2 ). Mandl's study (23) showed efficacy of hyaluronic acid (62 patients) on functional capacity and of placebo (62 patients) on pain at week 24 ( Table 2) . Figen Ayhan's study (19) (not included in the meta-analysis) compared with baseline but not together 2 groups of 29 patients. It indicated lower pain and improvement of functional capacity at week 24 after one injection of hyaluronic acid. Heyworth's study (21) (not included in the meta-analysis) showed no difference on pain and functional capacity at week 12 between hyaluronic acid (20 patients) and placebo (18 patients). The pooled analyses of the studies (74 patients in each arm) showed superiority of hyaluronic acid on functional capacity (SRM= -1.14 [-1.69; -0.60]) but not on pain (SRM= -0.95 [-3.87; 1.97]) (online figure S1 and Table 3 ).
Efficacy of hyaluronic acid versus corticosteroids injections
Mandl's study (23) showed no difference between corticosteroids (62 patients) and hyaluronic acid (62 patients) on functional capacity and pain at week 24 after 2 injections (Table 2 ). Monfort's study (25) compared two groups (48 patients for hyaluronic acid group, 40 for corticosteroids group) who received three injections. It showed efficacy of corticosteroids on functional capacity at week 12 and 24, with no difference on pain ( Table 2 ). Bahadir's study (22) compared two groups (20 patients in each) with one injection of corticosteroids or 3 of hyaluronic acid. It showed efficacy of hyaluronic acid on pain and functional capacity at all time points and on pulp pinch force at week 12 and 24 with large effect sizes ( Table 2 ). Stahl's study (27) showed efficacy of corticosteroids (25 patients) on pain at week 4 and of hyaluronic acid (27 patients) on pulp pinch force at week 24 after one injection (Table 2 ). Fuchs' study (20) (non included in the meta-analysis) compared 2 groups of 28 patients receiving 3 injections and indicated superiority of corticosteroids until week 12 and of hyaluronic acid on week 24 on pain. For pulp pinch force no difference was evidenced. Heyworth's study (21) (not included in the meta-analysis) indicated no difference on each outcome at all time points. Finally, 157 participants with hyaluronic acid and 147 with corticosteroids were available for the comparison of pain and functional capacity and 92 for the comparison on pulp pinch force ( Table 3) . The pooled analyses (Table 3) indicated no difference between hyaluronic acid and corticosteroids at short term follow-up but hyaluronic acid seemed superior on pulp pinch force status, and corticosteroids on pain at week 24 (online figure S1 and Table 3 ). For hyaluronic acid vs corticosteroids and pain at week 24, the results are almost entirely driven by a strongly positive study (N=40) while 3 other studies (N=274) found no effect.
Heterogeneity
The heterogeneity was significant for all outcomes: range of I² over the time points was respectively 85% to 97%, 34% to 95% and 0% to 82% for pain, functional capacity and pulp pinch force status (online Figure S1 ).
Discussion
This meta-analysis found great heterogeneity in the results. Against placebo, only hyaluronic acid appeared useful. However studies comparing hyaluronic acid and corticosteroids indicated hyaluronic acid may be useful in thumb OA in particular to increase functional capacity, and corticosteroid to decrease pain. These results should be further confirmed.
This study has some weaknesses. Despite the high prevalence of hand OA, there were few controlled trials in the literature, with a limited number of patients included in each. Many sources of heterogeneity were present among these studies. For example, the outcomes were heterogeneous. Pain, sometimes functional capacity and pulp pinch force were assessed, whereas the Outcome Measures in Rheumatology (OMERACT) consensus advises to evaluate joint activity and patient global assessment too (28) . For functional capacity, each study used a different score with some tests evaluating not only the hand but the arm in its globality. Only 2 studies used a score (Dreiser functional index (15)) validated in hand OA, according to the OMERACT Hand Osteoarthritis Group (28) . Length of folIow up was heterogeneous too, varying from 4 to 52 weeks, making difficult the comparison between the studies, which is why 3 different endpoints were used to better model the results. The number of injections was variable as was the technique of intra-articular injection making reproductibility and pooling difficult. In one study (26) , one injection of hyaluronic acid was considered as a placebo. This is based on a study realised in 1995 in knee OA which demonstrated that one injection of hyaluronic acid was no more effective than placebo. However, in the first carpo-metacarpal which is a small joint, only one injection may be sufficient. Finally, the majority of the studies used for this meta-analysis didn't have a high methodological quality highlighting the difficulties inherent to study design for injections trials. However this study also has strengths. This review and meta-analysis is important because of the frequency of thumb OA and its impact on everyday life (1, 2, 3 ). In this meta-analysis, the literature search was exhaustive, with searches in several databases and was updated over one year. The data extracted from the studies were analysed descriptively but also meta-analysed after having pooled the outcome measures in order to increase the strength of the analysis where possible. As the studies were heterogeneous in term of results and methodology, random effect models were used.
EULAR recommends intra-articular injections of corticosteroids in thumb OA but this recommendation was based on one small randomised controlled trial and one uncontrolled trial (5). Hyaluronic acid was also endorsed by the EULAR recommendations (5). The results of this meta-analysis may comfort the EULAR recommendations for hyaluronic acid and -less so -for corticosteroids. Furthermore, in knee OA, one study explored an associated injection of hyaluronic acid and corticosteroids: results were in favour of the association for the reduction of pain (30) . Synergy between these 2 drugs should be more explored. To conclude, our data suggest some benefit for hyaluronic acid and corticosteroids injections in thumb OA but the assessment of efficacy is limited by the heterogeneity of the results observed.
Other controlled trials with a higher number of patients would be useful.
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